Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadiye Sever
Observed names:
Nadiye SEVER,
SEVER, NADİYE,
Sever, Nadiye
Institutions:
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi,
Haydarpaşa Numune Eğitim ve Araştırma Hastanesi,
Marmara University
Observed institutions:
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi,
Erzurum Regional Training and Research Hospital,
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Haydarpaşa Numune Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Marmara University
show all 6
ORCID:
0000-0001-7312-3827
Observed ORCID:
0000-0001-7312-3827
OpenAlex ID:
A5041476271
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025
·
Nadiye Sever
, Fatih Şimşek
, et al.
·
Journal of Clinical Medicine
·
19
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
2025
·
Ali Kaan Güren
, Murad Guliyev
, et al.
·
Journal of Clinical Medicine
·
12
PDF
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023
·
Çağlar Ünal
, Abdulmunir Azizy
, et al.
·
The Oncologist
·
11
PDF
Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.
2025
·
Nadiye Sever
, Emil Yunusov
, et al.
·
PubMed Central
·
9
PDF
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
2024
·
Haci Arak
, Suna Erkiliç
, et al.
·
Journal of Immunotherapy
·
9
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024
·
Yusuf Ilhan
, Gokhan Ucar
, et al.
·
Expert Opinion on Pharmacotherapy
·
8
Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma
2024
·
Tarık Demir
, Murat Araz
, et al.
·
Clinical Lung Cancer
·
7
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024
·
İsmail Beypınar
, Hacer Demir
, et al.
·
Breast Cancer Research and Treatment
·
5
HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report
2024
·
Ali Kaan Güren
, Erkam Kocaaslan
, et al.
·
Anti-Cancer Drugs
·
5
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer
2024
·
Erdogan Selcuk Seber
, Yakup Iriagac
, et al.
·
Journal of College of Physicians And Surgeons Pakistan
·
5
PDF
Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
2023
·
Rukiye Arıkan
, Hilal Alkış
, et al.
·
Cureus
·
5
PDF
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
2026
·
Ali Kaan Güren
, Nazım Can Demircan
, et al.
·
Immunotherapy
·
4
The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy
2025
·
Ali Kaan Güren
, Zilan Başkan
, et al.
·
Medicina
·
4
PDF
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
2023
·
İbrahim Vedat Bayoğlu
, Javid Hüseynov
, et al.
·
Journal of Clinical Medicine
·
4
PDF
“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
2025
·
Serkan Yaşar
, Ahmet Kadıoğlu
, et al.
·
Medicina
·
3
PDF
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
2024
·
Nargiz Majidova
, Murat Sarı
, et al.
·
Oncology Research and Treatment
·
3
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026
·
Baris Koksal
, Hasan Cagri Yildirim
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma
2026
·
Burak Paçacı
, Erkam Kocaaslan
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab
2026
·
Erkam Kocaaslan
, Ali Kaan Güren
, et al.
·
Medicina
·
2
PDF
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis
2025
·
Sedat Yıldırım
, Tugba Başoğlu
, et al.
·
BMC Cancer
·
2
PDF
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey
2024
·
Nargiz Majidova
, Shahla Aghamaliyeva
, et al.
·
Journal of Chemotherapy
·
2
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
2024
·
Osman Köstek
, Ahmet Demirel
, et al.
·
Journal of Chemotherapy
·
2
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns
2026
·
Abdussamet Çelebi
, Nur Aybüke Bircan
, et al.
·
BMC Health Services Research
·
1
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study
2026
·
Sedat Yildirim
, Ozlem Nuray Sever
, et al.
·
Clinical Medicine Insights Oncology
·
1
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)
2026
·
Bengü Dursun
, Şendağ Yaslıkaya
, et al.
·
Cancers
·
1
PDF
Show more works
View as search
Works count:
67
Citation count:
140
H-index:
7
I10-index:
3
Year
Topic
Type